Neal Bhutiani

Oct 24, 2024 | ejso.com | Brian Badgwell |Neal Bhutiani |Y. Seo |Kristen Robinson |Michael White |Naruhiko Ikoma | +4 more

KeywordsHIPECgastric cancersurvivalGet full text accessLog in, subscribe or purchase for full access. References1. Ikoma, N. ∙ Chen, H.C. ∙ Wang, X. ... Patterns of Initial Recurrence in Gastric Adenocarcinoma in the Era of Preoperative TherapyAnnals of surgical oncology. Sep 2017; 24:2679-26872. Franko, J. ∙ Shi, Q. ∙ Meyers, J.P. ...

Oct 11, 2024 | digitalcommons.library.tmc.edu | Neal Bhutiani |Travis E. Grotz |Michael White |Seth J Concors

INTRODUCTION: Many patients with mucinous appendiceal adenocarcinoma experience peritoneal recurrence despite complete cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Prior work has demonstrated that repeat CRS/HIPEC can prolong survival in select patients. We sought to validate these findings using outcomes from a high-volume center.